Author： Berrie Christopher P
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.6, 2001-06, pp. : 1085-1098
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms
Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. :
Phosphoinositide 3-kinase signalling - which way to target?
By Wymann M.P. Zvelebil M. Laffargue M.
Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. :
Phosphoinositide 3-kinase α inhibitors: a patent review
Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. :